Acetazolamide from Japan
Acetazolamide is a carbonic anhydrase inhibitor used primarily as a diuretic and for glaucoma treatment, featuring an acyclic amide structure with a sulfonamide group. It falls under HTS 2924.19.80.00 as an acyclic amide derivative not specifically covered by other subheadings in 2924.19. This classification aligns with chapter notes for chemically defined organic compounds with amide functions.
Duty Rate — Japan → United States
21%
Rate breakdown
9903.04.628.5%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Verify pharmaceutical-grade purity certificates and comply with FDA import requirements for drug substances
• Include chemical analysis reports confirming acyclic amide structure to avoid reclassification
• Avoid common pitfalls like improper labeling of salts, which must follow the parent amide classification per chapter notes